RxSight, Inc. Unrealized Gain (Loss) on Investments
RxSight, Inc. (RXST) reported Unrealized Gain (Loss) on Investments of $70.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2026-08-05
- RxSight, Inc. unrealized gain (loss) on investments for the quarter ending 2026-06-30 was $5.00K, a 93.67% decline year-over-year.
- RxSight, Inc. unrealized gain (loss) on investments for the quarter ending 2026-03-31 was $65.00K, a 96.97% increase year-over-year.
- RxSight, Inc. unrealized gain (loss) on investments for the quarter ending 2025-12-31 was -$14.00K.
- RxSight, Inc. unrealized gain (loss) on investments for the quarter ending 2025-09-30 was -$45.00K, a 100.01% decline year-over-year.
- RxSight, Inc. unrealized gain (loss) on investments for fiscal 2024 was $190.00K, a 1800.00% increase from fiscal 2023.
- RxSight, Inc. unrealized gain (loss) on investments for fiscal 2023 was $10.00K, a 86.67% decline from fiscal 2022.
- RxSight, Inc. unrealized gain (loss) on investments for fiscal 2022 was $75.00K, a 733.33% increase from fiscal 2021.
- RxSight, Inc. unrealized gain (loss) on investments for fiscal 2021 was $9.00K, a 350.00% increase from fiscal 2020.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 3 month as first filed | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month | Unrealized Gain (Loss) on Investments 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $70.00K 10-Q · filed 2026-08-05 | $56.00K derived: sum of 3 quarters · filed 2026-08-05 | $11.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $65.00K 10-Q · filed 2026-05-06 | $51.00K derived: sum of 2 quarters · filed 2026-08-05 | $6.00K derived: sum of 3 quarters · filed 2026-08-05 | $85.00K derived: sum of 4 quarters · filed 2026-08-05 | ||
| 2025-12-31 | -$14.00K derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-05 | -$59.00K derived: sum of 2 quarters · filed 2026-08-05 | $20.00K derived: sum of 3 quarters · filed 2026-08-05 | $53.00K 10-Q · filed 2026-08-05 | ||
| 2025-09-30 | -$45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $34.00K derived: sum of 2 quarters · filed 2025-11-05 | $67.00K 10-Q · filed 2025-11-05 | -$532.74M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $112.00K 10-Q · filed 2025-08-07 | -$532.70M derived: sum of 3 quarters · filed 2026-02-25 | -$98.70M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2025-03-31 | $33.00K 10-Q · filed 2025-05-07 | -$532.78M derived: sum of 2 quarters · filed 2026-02-25 | -$98.78M derived: sum of 3 quarters · filed 2026-02-25 | -$35.78M derived: sum of 4 quarters · filed 2026-02-25 | ||
| 2024-12-31 | -$532.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$98.81M derived: sum of 2 quarters · filed 2026-02-25 | -$35.81M derived: sum of 3 quarters · filed 2026-02-25 | $190.00K 10-K · filed 2026-02-25 | ||
| 2024-09-30 | $434.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $497.00M derived: sum of 2 quarters · filed 2024-11-07 | $533.00M 10-Q · filed 2024-11-07 | $495.01M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2024-06-30 | $63.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $99.00M 10-Q · filed 2024-08-05 | $61.01M derived: sum of 3 quarters · filed 2025-02-25 | $42.01M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2024-03-31 | $36.00M 10-Q · filed 2024-05-06 | -$1.99M derived: sum of 2 quarters · filed 2025-02-25 | -$20.99M derived: sum of 3 quarters · filed 2025-02-25 | $26.01M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-12-31 | -$37.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$56.99M derived: sum of 2 quarters · filed 2025-02-25 | -$9.99M derived: sum of 3 quarters · filed 2025-02-25 | $10.00K 10-K · filed 2025-02-25 | ||
| 2023-09-30 | -$19.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $28.00M derived: sum of 2 quarters · filed 2023-11-09 | $38.00M 10-Q · filed 2023-11-09 | -$65.92M derived: sum of 4 quarters · filed 2024-05-06 | ||
| 2023-06-30 | $47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $57.00M 10-Q · filed 2023-08-07 | -$46.92M derived: sum of 3 quarters · filed 2024-05-06 | -$102.92M derived: sum of 4 quarters · filed 2024-05-06 | ||
| 2023-03-31 | $10.00M 10-Q · filed 2024-05-06 | $9.00K 10-Q · filed 2023-05-09 | -$93.92M derived: sum of 2 quarters · filed 2024-05-06 | -$149.93M derived: sum of 3 quarters · filed 2024-05-06 | -$72.92M derived: sum of 4 quarters · filed 2024-05-06 | |
| 2022-12-31 | -$103.92M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$159.93M derived: sum of 2 quarters · filed 2024-02-28 | -$82.92M derived: sum of 3 quarters · filed 2024-02-28 | $75.00K 10-K · filed 2024-02-28 | ||
| 2022-09-30 | -$56.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $21.00M derived: sum of 2 quarters · filed 2022-11-07 | $104.00M 10-Q · filed 2022-11-07 | $104.00M derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2022-06-30 | $77.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $160.00M 10-Q · filed 2022-08-08 | $160.00M derived: sum of 3 quarters · filed 2023-03-06 | $160.01M derived: sum of 4 quarters · filed 2023-03-06 | ||
| 2022-03-31 | $83.00M 10-Q · filed 2022-05-05 | $83.00M derived: sum of 2 quarters · filed 2023-03-06 | $83.01M derived: sum of 3 quarters · filed 2023-03-06 | |||
| 2021-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $8.00K derived: sum of 2 quarters · filed 2023-03-06 | $9.00K 10-K · filed 2023-03-06 | $9.00M 10-K · filed 2022-03-08 | ||
| 2021-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.00K 10-Q · filed 2021-11-10 | ||||
| 2021-06-30 | $1.00K 10-Q · filed 2021-09-09 | |||||
| 2020-12-31 | $2.00K 10-K · filed 2022-03-08 | -$2.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |